advertisement

Prostate cancer

06 June 2011

Cancer cells affect survival rates

The number of cancer cells that have broken off from the tumour and reached the blood stream affects the survival rate of patients suffering from prostate cancer.

The number of cancer cells that have broken off from the tumour and reached the blood stream affects the survival rate of patients suffering from advanced stages of prostate cancer, according to a study unveiled here.

A Phase III trial known as COU-AA that involved 1,195 patients showed that the drug Zytiga developed by US laboratory Johnson and Johnson significantly improved overall survival in patients with metastatic castration-resistant prostate cancer.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.